Teleflex Vascular Growth Faces Pressure From Higher Costs
Second-quarter Vascular revenue rose, but tariffs and acquisition-related costs weighed on Teleflex’s adjusted margins.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 58 of 89
Second-quarter Vascular revenue rose, but tariffs and acquisition-related costs weighed on Teleflex’s adjusted margins.
Stocks
The growth strategy said resilient biopharma demand and healthy third-quarter guidance supported its outlook for improving business into 2027.
Stocks
ClearBridge cited Meta as a leading quarterly contributor after strong reception to Muse, whose early downloads topped ChatGPT and Gemini debuts.
Stocks
StockStory cited recent earnings growth and a modest book-value forecast, while shares traded higher in Tuesday afternoon trading.
Stocks
The publisher cited modest earnings and tangible book value growth in its bearish view, while shares traded near $25 Tuesday afternoon.
Stocks
The bank will join a moderator-led discussion on Nov. 6, with a live listen-only webcast and a replay available afterward.
Stocks
The cosmetics company's shares fell over the past month, while analysts' forecasts showed gains for full-year earnings and sales.
Stocks
Adobe fell over the past month, while consensus earnings and sales estimates for the software company rose modestly, according to Zacks.
Stocks
Zacks reported a 14.4% monthly return for Amkor, while consensus earnings estimates for the current quarter and fiscal years were unchanged.
Stocks
Nasdaq staff notified the company on Oct. 1 that it met the exchange’s periodic filing requirement again.
Stocks
A JPMorgan strategist says Republican control would best support AI infrastructure as prediction markets price in a possible Democratic wave.
Stocks
The publisher pointed to Cardinal Health’s earnings growth while citing slower sales or weaker profitability at Omnicell and Lantheus.
Stocks
The cybersecurity ETF reached a record as major holdings climbed and warnings about rogue AI agents renewed attention on security spending.
Stocks
The publisher points to weak sales trends and falling earnings at Alamo, AECOM and Stanley Black & Decker.
Stocks
Everspin will mark a decade on Nasdaq with an October 8 ceremony, as it approaches 20 years of commercial MRAM production.
Stocks
The publisher flagged falling margins, weak sales outlooks and lower earnings per share at Edgewell, Inter Parfums and Bunge.
Stocks
The biopharmaceutical company plans to meet with registered investors during the Maxim Growth Summit in New York on October 12-14.
Stocks
The publisher pointed to AMETEK’s margins and Novanta’s growth outlook, while citing weaker cash-flow trends at Genco.
Stocks
The publisher cited revenue growth, margins and returns on capital at Lam Research, O’Reilly Automotive and Xylem.
Stocks
The publisher cited Copart’s revenue growth and returns while pointing to weaker growth or cash-flow concerns at two other companies.
Stocks
The publisher points to RTX’s revenue and earnings growth, while citing slower growth and other concerns at F5 and Packaging Corporation of America.
Stocks
Freshworks will replace BioLife Solutions in the index as Repligen’s acquisition of BioLife nears completion, subject to final closing conditions.
Stocks
The publisher points to weaker billings, declining gross margins and cash use despite C3.ai’s share gains over six months.
Stocks
The stock outpaced the S&P 500 in its latest session, while Zacks estimates point to lower quarterly earnings and revenue.
Stocks